Autologous Organ Transplantation represents a ground-breaking approach in the field of transplant medicine, offering a potential solution to the longstanding challenges of organ rejection and donor shortages. Unlike traditional organ transplants, where organs are sourced from external donors, autologous transplantation involves transplanting tissues or organs that are derived from the patient's own body. This eliminates the risk of rejection by the recipient's immune system, as the transplanted tissue is genetically identical to the recipient's own cells. The process typically involves harvesting healthy tissue from the patient, often through biopsy or surgical excision, and then growing and/or modifying the tissue ex vivo before transplantation. This approach is particularly promising for regenerative medicine applications, where damaged or diseased tissues can be replaced with healthy autologous grafts, thereby promoting tissue repair and regeneration. Autologous transplantation is already being used in clinical settings for procedures such as autologous skin grafts for burn victims and autologous bone marrow transplants for patients with hematologic malignancies. In recent years, advances in stem cell biology and tissue engineering have expanded the possibilities for autologous transplantation, enabling the regeneration of complex tissues and organs such as cartilage, blood vessels, and even organs like the liver and kidneys. However, challenges remain in scaling up these techniques for widespread clinical use, including the need for efficient methods of tissue harvesting, processing, and transplantation, as well as the high cost and complexity of the procedures. Moreover, autologous transplantation may not be feasible for all patients, particularly those with certain genetic or medical conditions that preclude the use of their own tissues. Despite these challenges, autologous organ transplantation holds immense promise for improving patient outcomes and addressing the growing demand for donor organs. With continued research and technological innovation, autologous transplantation has the potential to revolutionize the field of transplant medicine and pave the way for personalized regenerative therapies tailored to individual patients' needs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy